Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Prolapse surgery without overnight stay? new study tests feasibility

NCT ID NCT03573752

First seen Jan 10, 2026 · Last updated Jun 22, 2026 · Updated 23 times

Summary

This study looked at whether laparoscopic promontofixation, a common surgery for pelvic organ prolapse, can be safely performed as an outpatient procedure. Sixty women who needed the surgery were discharged 8 hours after the operation. The main goal was to see how many needed to be readmitted to the hospital. Patients also filled out questionnaires about their pain, anxiety, and overall satisfaction.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Service de gynécologie, Centre Médico Chirurgical Obstétrical, Hôpitaux Universitaires de Strasbourg

    Schiltigheim, 67303, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

outpatient management (early discharge after laparoscopic promontofixation)

What this could lead to

If successful, this could show that laparoscopic prolapse repair can be safely done as outpatient surgery, reducing hospital stays and healthcare costs.

What could go wrong

This is a small, single-center study with only 60 participants, so results may not apply broadly. Outpatient management may not be suitable for all patients, and there is a risk of complications requiring readmission.

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.